Zydus Lifesciences gets USFDA nod for generic cholesterol lowering drug
Zydus Lifesciences
Ltd on Wednesday said it has received final approval from the US health regulator to manufacture the generic version of
cholesterol
lowering Niacin extended-release tablets. The approval by the US Food and Drug Administration (USFDA) is for Niacin extended-release tablets of strengths 500 mg, 750 mg, and 1,000 mg, Zydus Lifesciences Ltd said in a regulatory filing.
#Pahalgam Terrorist Attack
The groundwork before India mounts a strike at Pakistan
India considers closing airspace to Pakistani carriers amid rising tensions
Cold Start: India's answer to Pakistan's nuclear threats
The Niacin-extended-release tablets will be produced at the group's manufacturing site at Moraiya, Ahmedabad, the company said.
Niacin is indicated to reduce elevated total cholesterol (TC), LDL cholesterol (LDL-C), apolipoprotein B (Apo B), and triglycerides (TG), and to increase HDL cholesterol (HDL-C) in patients with primary hyperlipidaemia and mixed dyslipidaemia.
It is also indicated to reduce the risk of recurrent myocardial infarction in patients with a history of myocardial infarction and hyperlipidaemia and to reduce TG (triglyceride) in adult patients with severe hypertriglyceridemia.
Citing IQVIA MAT February (2025) data, the company said the niacin-extended-release tablets had annual sales of USD 5.5 million in the United States.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
11 hours ago
- Time of India
Redefining Indian Healthcare Ecosystem: Rise of the Everyday Care Economy with preventive health
Indian healthcare has traditionally been known for curative treatment placing significant burden on Indian healthcare infrastructure coupled with sizable healthcare spending. However, with the rapid rise in non-communicable diseases (NCDs), more awareness around health and wellness in the post-pandemic era, Indian healthcare industry is undergoing a profound transformation. We are now seeing the emergence of ' Everyday Care economy' which is fast pivoting towards preventive healthcare empowering consumers to take control of their health. Today, self-care has evolved and has become more inclusive, encompassing preventive care, long-term wellness, mental well-being, health tracking and diagnosis and is fast becoming part of everyday rituals. At the heart of this new paradigm, self-care, is rapidly emerging as a foundational pillar of India n healthcare ecosystem promising not only improved health outcomes, but also a more productive workforce, reduced healthcare costs and improved savings. There is no better time than now for the India's self-care/Care ecosystem. With a rising and informed middle class and increasing digital penetration, more Indians are prioritizing health not only in response to illness but as a lifestyle choice to keep health problems at bay or prepare for them proactively. Empowered by access to information, growing health consciousness, and digital tools, India's health and wellness market is expected to reach USD 256.9 billion by 2033 (IMARC), with demand for products and practices that support holistic preventive care/well-being/everyday care is on the rise. Self-Care: A huge opportunity, low adoption The global consumer healthcare (CH) market was valued at over USD 700 billion in 2024 (Source-IQVIA) and is growing steadily. Within this landscape, India is gaining prominence, ranking 8th globally and 3rd in the Asia-Pacific region in consumer health sales. The Indian consumer health market stood at USD 4.9 billion in 2023, growing at a strong 9.8% annually (Source-Nicolas Hall), with personal care and beauty, nutrition, patient care and OTC treatments to self-manage minor ailments and conditions emerging as key categories. Looking ahead, the global consumer market is projected to grow at a 6.5 per cent CAGR through 2030—India, by contrast, is expected to grow nearly double that rate at 12 per cent CAGR over the same period (IQVIA), indicating the massive growth potential of India. Despite this latent opportunity, India still has considerable ground to cover. Today, the Asia-Pacific region accounts for 60% of the world's population but just 9 per cent of global health spending, highlighting the critical need for greater awareness and improved accessibility of self-care solutions. In comparison, preventive health has gained momentum in global markets with telehealth, wearables, and health apps making self-care more accessible coupled with increased trust in pharmacies and OTC wellness solutions providing consumers with effective, affordable everyday products. As we move ahead, we see some distinct trends shaping India's consumer health/care/everyday economy In India, self-care is influenced by unique environmental and cultural factors. For instance, India recorded unprecedented 280 heat wave days in 2022, a 55 per cent increase in deaths due to extreme heat in last two decades, with UN forecasting next five years to be hottest period ever making more people vulnerable to dehydration as well as necessitating holistic hydration strategies with fluid, electrolytes, and energy (FEE) solutions to recover faster as well as strengthen immunity. Oral health is also gaining importance. According to the World Health Organization , over 95 per cent of Indian adults suffer from cavities as well as gum problems, bad breath issues while most children do not brush twice a day. These numbers highlight the urgent need to reinforce oral health habits and promote preventive care with mouthwashes and related oral care solutions being adopted as part of daily preventive care. Skin health and beauty is also gaining attention, with the rise of science, ingredient efficacy, sensitive skin, and repair in both skin and hair. According to new research from Astute Analytica, India's skin care market was valued at USD 8.78 billion in 2024 and is projected to reach USD 17.69 billion by 2033. In the skin health category, we are increasingly seeing a shift towards premiumization in the skincare category, with clean beauty and ingredient transparency gaining prominence. Personalization is another major trend shaping the Indian skincare market. Consumers increasingly demand products tailored to their unique skin types and concerns, fuelling the rise of AI-powered skin diagnosis tools and customized regimens. Factors such as pollution, climate-related triggers, stress are intensifying this need with a growing demand for dermatologist-recommended and science backed formulations as well as specialised solutions to tackle specific and sensitive skin conditions like atopic dermatitis and eczema. In India's journey toward self-care and healthcare resilience, pharmacies will play a pivotal role from treatment-based healthcare to a more prevention and OTC focused approach. However, for this shift to be successful, it requires greater systemic support. Policymakers also have a crucial role to play. Strengthening regulatory frameworks for OTC and wellness products is essential to ensure quality and safety. Public-private partnerships can further accelerate this transformation, making wellness more inclusive, scalable, and sustainable. The Indian government's Swasth Nagrik Abhiyan further reinforces this movement, placing preventive care at the heart of national health strategy. By focusing on lifestyle diseases and communicable health threats alike, the initiative creates a strong policy environment to support the growth of self-care. It also offers a significant opportunity for private players to collaborate, innovate, and contribute meaningfully to public health outcomes. The rise of the care economy is not merely a business trend. It is a societal shift which positively impacts consumers, healthcare systems and society at large. For consumer health companies like us, this provides both an opportunity and responsibility. To thrive in this evolving landscape, companies must innovate not only in products but also in how we engage, educate, and empower consumers working closely with healthcare professionals, pharmacists and policymakers, to nurture a healthier India. This article is written by Manish Anandani , Managing Director, Kenvue India
Business Standard
2 days ago
- Business Standard
Aayush Wellness Limited to Form Wholly Owned Subsidiary in Singapore to Drive Southeast Asia Expansion
VMPL New Delhi [India], June 10: Aayush Wellness Limited [BSE:539528], an integrated healthcare company dedicated to holistic wellness and innovation, is pleased to announce that its Board of Directors has approved the formation of a wholly owned subsidiary in Singapore with an initial capital investment of SGD 10,000. Highlights:- * Aayush Wellness Limited Stock Price at 52 week High of Rs. 151.05 per share * Income from Operations jump multifold to Rs. 73.34 crore in FY 2024-25 * Net Profit for FY 25 was reported at Rs. 3.05 crore, 434% rise Y-o-Y * Company is planning expansion into preventive healthcare with Smart Health Kiosks & Medical Support centre; To Invest upto Rs. 25 crore in the expansion This strategic expansion marks a significant step in the company's global growth strategy and will serve as a launchpad for its nutraceutical and healthcare products across the rapidly expanding Southeast Asian markets. Mr. Naveena Kumar, Managing Director of Aayush Wellness said, "Our new Singapore-based subsidiary will enable us to tap into one of the world's most dynamic wellness markets, offering greater agility in operations, regulatory efficiency, and direct access to high-growth ASEAN economies. This is a critical step toward building a global wellness brand." Unlocking Regional Potential: The Southeast Asian nutraceutical market is projected to reach USD 15.1 billion by 2028, growing at a CAGR of 7.5%, driven by rising health consciousness, urbanization, and preference for preventive healthcare solutions. Singapore, in particular, stands out as a key market and gateway for regional expansion. The country's nutraceutical sector is valued at over USD 1.3 billion, with steady growth driven by an aging population, high per capita health spending, and a consumer base that actively seeks functional foods, dietary supplements, and herbal wellness solutions. Its strong regulatory framework and international connectivity make it an ideal base for Aayush Wellness's global ambitions. Key Focus Areas of the Subsidiary: * Localizing product offerings to align with regulatory and cultural preferences. * Forging strategic partnerships and e-commerce distribution channels across ASEAN. * Driving export growth from India while expanding the company's international brand presence. * Establishing a regional R & D and innovation hub to adapt to market-specific wellness trends. Aligned with Aayush Wellness's Vision: This development is in line with Aayush Wellness Limited's broader mission to deliver science-backed, sustainable, and natural healthcare solutions globally. The company aims to use its new presence in Singapore to not only access markets in Malaysia, Indonesia, Thailand, and Vietnam, but also to establish a foundation for future global partnerships and innovation. For the Financial year 2024-25 ended 31st March 2025. company has reported income from operations of Rs. 73.34 crore for FY2024-25, multifold growth as compared to the income from operations of Rs. 60 lakh in the corresponding period last year. Net profit of the company for the FY 2024-25 was reported at Rs. 3.05 crore, 434% rise Y-o-Y as compared to the net profit of Rs. 57 lakh in the corresponding period in FY 2023-24. The stock price was up and touched 52 week high of Rs. 151.05 per share on 9 June 2025. The share price was in the buyer circuit for the last many days with good volumes. Aayush Wellness is also taking ambitious strides into offline preventive healthcare. Company has launched its first healthcare centre in Virar (Mumbai), Maharashtra. Inspired by the E Sanjeevani National Telemedicine Service of the Ministry of Health and Family Welfare, Aayush Wellness has installed a health ATM that shall conduct a wide range of diagnostics tests, in 2-3 minutes, maintain digital health records, and also facilitate Telemedicine to address health deficiencies before they become critical. The Company plans to invest up to Rs. 25 crores in the first phase and shall review further investments based on business requirements. This expansion will increase company's physical presence across geographies all over India, improve the offline distribution network for our products and provide complete preventive healthcare solutions under one roof. The Cloud Clinic model through this Health ATM is unique as it will deliver affordable yet high quality healthcare services to under privileged population of India. Solution offer by the company not only promotes early detection and prevention but also empowers individuals, especially those in rural and semi-urban areas, to take charge of their health in an accessible, cost-effective manner." The health ATM shall be able to conduct a up to 59 test including blood test, sugar test, Urine test, Haemoglobin test, skin test, eye test, cancer risk test, Lipid Profile test, and other basic health checkups, at a very affordable price. Further, the health ATM shall also facilitate Telemedicine, maintain Digital Health Records, Cloud connectivity generates smart reports and integration with Ayushman Bharat Digital Mission to benefit majority of the Indian Population About Aayush Wellness Limited: (ISO 9000 and 22000 certified company) Aayush Wellness Limited [BSE scrip code: 539528], established in 1989 is a pioneering name in health and wellness solutions, dedicated to offering products that merge wellbeing with innovation. We are India's preventive healthcare company committed to offer quality products and services to enhance the consumer well-being. Aayush Wellness continues to lead the industry in promoting healthier lifestyle choices through its diverse range of wellness products and services. For more information, please visit
News18
2 days ago
- News18
Bengaluru Stampede: RCB Owner Discussing Sale Of IPL Franchise
According to Bloomberg, the alcohol company may seek a valuation of USD 2 billion and is currently in discussions with advisers. However, no final decision has been made, and it is possible that they may not sell the team. Currently, RCB is embroiled in a major controversy after an event organised by them to celebrate the franchise's IPL triumph turned tragic. A large crowd gathered outside the M. Chinnaswamy Stadium to catch a glimpse of the RCB cricketers, with the franchise having announced a victory parade and felicitation. A stampede ensued outside the cricket stadium, resulting in the deaths of eleven people and injuries to several others. The incident sparked nationwide outrage, leading to the filing of an FIR against RCB, the event organiser DNA Entertainment Networks Private Limited, and the Karnataka State Cricket Association. Furthermore, before the start of IPL 2025, the Indian Ministry of Health issued an advisory urging the organisers of the popular cricket tournament to ban all tobacco and alcohol advertising, including surrogate promotions, during matches and broadcasts, citing public health concerns. The Director General of Health Services, Atul Goel, wrote in a letter to IPL chairman Arun Singh Dhumal, 'IPL should strictly implement the regulations banning all forms of tobacco/alcohol advertising, including surrogate advertisements, within the stadium premises where the games and related IPL events are held, as well as during telecast sessions on national television." RCB won the IPL championship for the first time in their history after defeating Punjab Kings in a thrilling final held in Ahmedabad last week.
